scispace - formally typeset
K

Kunpeng Mu

Researcher at Northeastern University

Publications -  8
Citations -  3102

Kunpeng Mu is an academic researcher from Northeastern University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 1, co-authored 1 publications receiving 2084 citations.

Papers
More filters
Journal ArticleDOI

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.

TL;DR: The results suggest that early detection, hand washing, self-isolation, and household quarantine will likely be more effective than travel restrictions at mitigating this pandemic, and sustained 90% travel restrictions to and from mainland China only modestly affect the epidemic trajectory unless combined with a 50% or higher reduction of transmission in the community.
Journal ArticleDOI

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States

Estee Y Cramer, +294 more
TL;DR: In this paper , the authors compared the probabilistic accuracy of short-term forecasts of reported deaths due to COVID-19 during the first year and a half of the pandemic in the United States.
Posted ContentDOI

Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa

TL;DR: A stochastic, multi-strain, compartmental epidemic model to estimate the relative transmissibility and immune escape of the Omicron variant of concern (VOC) in South Africa is developed and it is found that changes in the generation time associated with Omicrons infections strongly affect the results concerning its relativetransmissibility.
Journal ArticleDOI

Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study

TL;DR: The COVID-19 Scenario Modeling Hub convened nine modeling teams to project the impact of expanding SARS-CoV-2 vaccination to children aged 5-11 years on burden and resilience against variant strains as discussed by the authors .
Journal ArticleDOI

Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: a multi-model study

TL;DR: The COVID-19 Scenario Modeling Hub convened nine modeling teams to project the impact of expanding SARS-CoV-2 vaccination to children aged 5-11 years on burden and resilience against variant strains as discussed by the authors .